Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06798753 · ClinicalTrials.gov registry record · NA

Occlusion Balloon vs. 5FR Ureteral Catheter

A NA study, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT06798753: Completed NA study, sponsored by Icahn School of Medicine at Mount Sinai.

NCT06798753 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06798753, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

Occlusion Balloon catheter provides the ability to occlude the exit of the kidney pelvis during percutaneous nephrolithotomy (PCNL) and potentially prevents the migration of stone fragments into the ureter. The necessity for it might be questioned during supine PCNL due to the upward oblique position of the kidney. The objective of the study is to compare the presence of ureteral stone fragments upon completion of supine PCNL with and without using an occlusion balloon catheter (OBC).

Primary Outcome

Endoscopic identification of ureteral stone fragments will be used to compare rate of ureteral stone fragments upon completion of PCNL while using OBC versus 5FR-UC.

Interventions

  • DEVICE Occlusion Balloon Catheter
  • DEVICE 5FR Ureteral Catheter

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2025-01-23
Est. Completion 2025-08-29
Phase NA

What the finished NCT06798753 record still lists

NCT06798753 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Occlusion Balloon Catheter is the first listed.

NCT06798753 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06798753 about?

NCT06798753 is a clinical study titled "Occlusion Balloon vs. 5FR Ureteral Catheter". Occlusion Balloon catheter provides the ability to occlude the exit of the kidney pelvis during percutaneous nephrolithotomy (PCNL) and potentially prevents the migration of stone fragments into the ureter. The necessity for it might be questioned during supine PCNL due to the upward oblique positio...

What is the current status of trial NCT06798753?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2025-01-23. Estimated completion is 2025-08-29.

What interventions are being tested in trial NCT06798753?

The interventions under investigation include: Occlusion Balloon Catheter (DEVICE), 5FR Ureteral Catheter (DEVICE).

Who is sponsoring clinical trial NCT06798753?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06798753's enrollment target sits among peer trials

108 825th of 2000 higher than 1,171 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06798753, the US trial registry maintained by the National Library of Medicine. NCT06798753 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.